Interstitial Lung Disease Associated With the Idiopathic Inflammatory Myopathies

2010/12/01 by Geoffrey R. Connors, Lisa Christopher-Stine, Lisa Christopher‐Stine +2 · 27 citations
Medicine · #Inflammatory Myopathies and Dermatomyositis #Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis #Parkinson's Disease and Spinal Disorders

paper · doi:10.1378/chest.10-0180

Cited by

• Clinical Profiles and Lung Function Trajectories of Patients With Idiopathic Inflammatory Myopathy Associated Interstial Lung Disease
• FAPI PET/CT for tracking disease trajectory in myositis-related interstitial lung disease
• The importance of including amyopathic dermatomyositis in the idiopathic inflammatory myositis spectrum. [europepmc]
• Dense genotyping of immune-related loci in idiopathic inflammatory myopathies confirms HLA alleles as the strongest genetic risk factor and suggests different genetic background for major clinical subgroups. [europepmc]
• Benefit of adjunctive tacrolimus in connective tissue disease-interstitial lung disease. [europepmc]
• Management of interstitial lung disease associated with connective tissue disease. [europepmc]
• Factors Associated with Interstitial Lung Disease in Patients with Polymyositis and Dermatomyositis: A Systematic Review and Meta-Analysis. [europepmc]
• The Diagnosis and Treatment of Antisynthetase Syndrome. [europepmc]
• Comparative analyses of muscle MRI and muscular function in anti-synthetase syndrome patients and matched controls: a cross-sectional study. [europepmc]
• Role of Autoantibodies in the Diagnosis of Connective-Tissue Disease ILD (CTD-ILD) and Interstitial Pneumonia with Autoimmune Features (IPAF). [europepmc]
• The EuroMyositis registry: an international collaborative tool to facilitate myositis research. [europepmc]
• Identification of multiple cancer-associated myositis-specific autoantibodies in idiopathic inflammatory myopathies: a large longitudinal cohort study. [europepmc]
• Rituximab in the Treatment of Interstitial Lung Disease Associated with Antisynthetase Syndrome: A Multicenter Retrospective Case Review. [europepmc]
• Autoantibodies Associated With Connective Tissue Diseases: What Meaning for Clinicians? [europepmc]
• Clinical features and outcome of patients with acute respiratory failure revealing anti-synthetase or anti-MDA-5 dermato-pulmonary syndrome: a French multicenter retrospective study. [europepmc]
• Long-term treatment with human immunoglobulin for antisynthetase syndrome-associated interstitial lung disease. [europepmc]
• Interstitial Pneumonia With Autoimmune Features (IPAF). [europepmc]
• Therapeutic Options for the Treatment of Interstitial Lung Disease Related to Connective Tissue Diseases. A Narrative Review. [europepmc]
• Machine learning algorithms reveal unique gene expression profiles in muscle biopsies from patients with different types of myositis. [europepmc]
• Myositis-specific antibodies identify a distinct interstitial pneumonia with autoimmune features phenotype. [europepmc]
• Diagnosis and management of connective tissue disease-associated interstitial lung disease in Australia and New Zealand: A position statement from the Thoracic Society of Australia and New Zealand. [europepmc]
• Clinical features of anti-synthetase syndrome associated interstitial lung disease: a retrospective cohort in China. [europepmc]
• A narrative review of interstitial lung disease in anti-synthetase syndrome: a clinical approach. [europepmc]
• Interstitial pneumonia with autoimmune features: challenges and controversies. [europepmc]
• Defining anti-synthetase syndrome: a systematic literature review. [europepmc]
• Pathophysiological Mechanisms and Treatment of Dermatomyositis and Immune Mediated Necrotizing Myopathies: A Focused Review. [europepmc]
• Aminoacyl-tRNA Synthetases: On Anti-Synthetase Syndrome and Beyond. [europepmc]